A new analysis found that the National Institutes of Health is funding more conservative research projects, which does not promote great new discoveries, the authors argue.
In a study, paralyzed people with tiny brain implants were able to directly operate a tablet just by thought.
With age comes wisdom: mostly true. But a new study helps explain why one part of us - our immune system - gets decidedly dumber with age.
In this piece, Dean Lloyd Minor argues that doctors and researchers have a responsibility to educate people about the role and value of science.
DNA looping, or folding, directs a cell's developmental fate. Harnessing this 'DNA origami' could help researchers generate specific tissues for therapies.
A novel immunotherapy appears safe for use in patients with non-Hodgkin’s lymphoma. Here, a Northern California man shares his experience in the study.
The anti-inflammatory drug ketoprofen shows promise as effective medical treatment for lymphedema symptoms, small Stanford study finds
Cancerous tumors cause disease in two ways: they grow and spread. But a new immune therapy approach may be able to target both problems simultaneously.
Your trillions-strong ecosystem of gut microbes, in addition to its many other responsibilities, operates as a homespun pharmaceutical factory.
Much of what we know about the immune system comes from experiments conducted on mice. But lab mice are not little human beings. The two species are separated by both physiology and lifestyles. Stanford immunologist Mark Davis is calling on his colleagues to shift their research focus to people.
Scientists find new potential drug targets for heart disease and diabetes, while shedding more light on the genetics of cholesterol, a new study has found.
As someone who had spent her career studying molecules on a computer screen, experiments involving people were a revelation and inspiration for Jane Tseng, PhD, …
Scientists have measured the human “exposome,” or the particulates, chemicals, and microbes that individually swarm us all, in unprecedented detail.
John Ioannidis reflects on the phenomenon of "hyper-publishing," where certain scientists are listed as authors on scores of papers a year.
A new Stanford-led study catalogs the prevalence and types of deception by volunteers in clinical trials and suggests ways for investigators to root it out.
Stanford Biodesign trainees have developed new medical devices and diagnostics that have been used to help care for more than 1.5 million patients so far.